Latonya Been

7.9k total citations
36 papers, 835 citations indexed

About

Latonya Been is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Latonya Been has authored 36 papers receiving a total of 835 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cardiology and Cardiovascular Medicine, 18 papers in Surgery and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Latonya Been's work include Antiplatelet Therapy and Cardiovascular Diseases (25 papers), Lipoproteins and Cardiovascular Health (14 papers) and Atrial Fibrillation Management and Outcomes (7 papers). Latonya Been is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (25 papers), Lipoproteins and Cardiovascular Health (14 papers) and Atrial Fibrillation Management and Outcomes (7 papers). Latonya Been collaborates with scholars based in United States, Italy and India. Latonya Been's co-authors include Dharambir K. Sanghera, Francesco Franchi, Fabiana Rollini, Dominick J. Angiolillo, Sarju Ralhan, Gurpreet Singh Wander, Christopher E. Aston, Martin M. Zenni, Theodore A. Bass and Andrea Rivas and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Latonya Been

35 papers receiving 819 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Latonya Been United States	19	508	312	157	150	131	36	835
Lisa Dannenberg Germany	14	374 0.7×	173 0.6×	40 0.3×	24 0.2×	158 1.2×	62	678
Anders Bröijersén Sweden	15	289 0.6×	212 0.7×	124 0.8×	16 0.1×	121 0.9×	27	719
Bert D. Dikkeschei Netherlands	14	246 0.5×	289 0.9×	164 1.0×	40 0.3×	87 0.7×	23	650
Elisabetta Trabetti Italy	8	286 0.6×	153 0.5×	95 0.6×	20 0.1×	53 0.4×	8	452
Birgit Svensson Norway	14	169 0.3×	203 0.7×	111 0.7×	20 0.1×	63 0.5×	29	623
Takehiro Igawa Japan	10	211 0.4×	189 0.6×	46 0.3×	25 0.2×	142 1.1×	20	562
D. A. Zateyshchikov Russia	8	289 0.6×	133 0.4×	47 0.3×	13 0.1×	78 0.6×	72	428
Kazue Ishikawa Japan	11	152 0.3×	112 0.4×	153 1.0×	40 0.3×	127 1.0×	19	453
Wolfgang Latz Germany	5	313 0.6×	177 0.6×	114 0.7×	16 0.1×	41 0.3×	5	508
Jana Matusková Slovakia	11	208 0.4×	110 0.4×	99 0.6×	9 0.1×	102 0.8×	16	577

Countries citing papers authored by Latonya Been

Since Specialization

Citations

This map shows the geographic impact of Latonya Been's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Latonya Been with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Latonya Been more than expected).

Fields of papers citing papers by Latonya Been

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Latonya Been. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Latonya Been. The network helps show where Latonya Been may publish in the future.

Co-authorship network of co-authors of Latonya Been

This figure shows the co-authorship network connecting the top 25 collaborators of Latonya Been. A scholar is included among the top collaborators of Latonya Been based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Latonya Been. Latonya Been is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ortega‐Paz, Luis, Francesco Franchi, Fabiana Rollini, et al.. (2024). Clopidogrel-Mediated P2Y12 Inhibition According to Renal Function in Patients With Diabetes Mellitus and CAD. JACC Basic to Translational Science. 9(7). 865–876. 2 indexed citations

Franchi, Francesco, Luis Ortega‐Paz, Fabiana Rollini, et al.. (2023). Impact of evolocumab on the pharmacodynamic profiles of clopidogrel in patients with atherosclerotic cardiovascular disease: a randomised, double-blind, placebo-controlled study.. PubMed. 18(15). 1254–1265. 9 indexed citations

Ortega‐Paz, Luis, Francesco Franchi, Fabiana Rollini, et al.. (2023). Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study. Thrombosis and Haemostasis. 124(3). 263–273. 9 indexed citations

Franchi, Francesco, Fabiana Rollini, Luis Ortega‐Paz, et al.. (2023). Switching From Cangrelor to Prasugrel in Patients Undergoing Percutaneous Coronary Intervention. JACC: Cardiovascular Interventions. 16(20). 2528–2539. 10 indexed citations

Galli, Mattía, Francesco Franchi, Fabiana Rollini, et al.. (2022). Platelet P2Y12 inhibiting therapy in adjunct to vascular dose of rivaroxaban or aspirin: a pharmacodynamic study of dual pathway inhibition vs. dual antiplatelet therapy. European Heart Journal - Cardiovascular Pharmacotherapy. 8(7). 728–737. 17 indexed citations

Franchi, Francesco, Luis Ortega‐Paz, Fabiana Rollini, et al.. (2022). Cangrelor in Patients With Coronary Artery Disease Pretreated With Ticagrelor. JACC: Cardiovascular Interventions. 16(1). 36–46. 18 indexed citations

Galli, Mattía, Francesco Franchi, Fabiana Rollini, et al.. (2022). Pharmacodynamic Profiles of Dual-Pathway Inhibition with or without Clopidogrel versus Dual Antiplatelet Therapy in Patients with Atherosclerotic Disease. Thrombosis and Haemostasis. 122(8). 1341–1351. 21 indexed citations

Franchi, Francesco, Fabiana Rollini, Latonya Been, et al.. (2021). Impact of chronic kidney disease on the pharmacodynamic and pharmacokinetic effects of ticagrelor in patients with diabetes mellitus and coronary artery disease. European Heart Journal - Cardiovascular Pharmacotherapy. 8(5). 452–461. 5 indexed citations

Franchi, Francesco, Fabiana Rollini, Andrea Rivas, et al.. (2020). Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-Function Genotypes. JACC Basic to Translational Science. 5(5). 419–428. 23 indexed citations

10.

Franchi, Francesco, Fabiana Rollini, Niti R. Aggarwal, et al.. (2016). Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease. Circulation. 134(11). 780–792. 70 indexed citations

11.

Franchi, Francesco, Fabiana Rollini, Yongwhi Park, et al.. (2016). Abstract 19115: Effect of the Peripheral Opioid Receptor Antagonist Methylnaltrexone on the Pharmacokinetic and Pharmacodynamic Profiles of Ticagrelor in Patients Receiving Morphine: A Prospective Randomized Placebo-Controlled Trial. Circulation. 134. 2 indexed citations

12.

Franchi, Francesco, Gabriel Faz, Fabiana Rollini, et al.. (2016). Pharmacodynamic Effects of Switching From Prasugrel to Ticagrelor. JACC: Cardiovascular Interventions. 9(11). 1089–1098. 28 indexed citations

13.

Franchi, Francesco, Fabiana Rollini, Valeria E. Duarte, et al.. (2016). A PHARMACODYNAMIC COMPARISON OF PRASUGREL VERSUS TICAGRELOR IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CORONARY ARTERY DISEASE: THE OPTIMUS (OPTIMIZING ANTIPLATELET THERAPY IN DIABETES MELLITUS)-4 STUDY. Journal of the American College of Cardiology. 67(13). 22–22. 4 indexed citations

14.

Faz, Gabriel, Fabiana Rollini, Francesco Franchi, et al.. (2016). PHARMACODYNAMIC EFFECTS OF SWITCHING FROM PRASUGREL TO TICAGRELOR: RESULTS OF THE PROSPECTIVE, RANDOMIZED SWAP (SWITCHING ANTI PLATELET)-3 STUDY. Journal of the American College of Cardiology. 67(13). 215–215. 1 indexed citations

15.

Howard, Eric W., Latonya Been, Megan R. Lerner, et al.. (2013). Carriers of a novel frame-shift insertion in WNT16a possess elevatedpancreatic expression of TCF7L2. BMC Genetics. 14(1). 28–28. 5 indexed citations

16.

Been, Latonya, et al.. (2011). Genetic variation in cholesterol ester transfer protein, serum CETP activity, and coronary artery disease risk in Asian Indian diabetic cohort. Pharmacogenetics and Genomics. 22(2). 95–104. 33 indexed citations

17.

Been, Latonya, Aparna Shankar, Christopher E. Aston, et al.. (2011). A low frequency variant within the GWAS locus of MTNR1B affects fasting glucose concentrations: Genetic risk is modulated by obesity. Nutrition Metabolism and Cardiovascular Diseases. 22(11). 944–951. 27 indexed citations

18.

Sanghera, Dharambir K., F. Yesim Demirci, Latonya Been, et al.. (2009). PPARG and ADIPOQ gene polymorphisms increase type 2 diabetes mellitus risk in Asian Indian Sikhs: Pro12Ala still remains as the strongest predictor. Metabolism. 59(4). 492–501. 54 indexed citations

19.

Been, Latonya, Swapan K. Nath, Sarju Ralhan, et al.. (2009). Replication of Association Between a Common Variant Near Melanocortin‐4 Receptor Gene and Obesity‐related Traits in Asian Sikhs. Obesity. 18(2). 425–429. 31 indexed citations

20.

Sanghera, Dharambir K., Latonya Been, Gurpreet Singh Wander, et al.. (2009). Testing the association of novel meta-analysis-derived diabetes risk genes with type II diabetes and related metabolic traits in Asian Indian Sikhs. Journal of Human Genetics. 54(3). 162–168. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact